Study Finds Safer Alternatives for Golden Staph Bloodstream Infections

The international SNAP Trial, published in prominent medical journals, challenges the conventional treatment approach for golden staph bloodstream infections. The extensive study, involving over 150 hospitals globally, found that cefazolin and benzylpenicillin are equally effective as flucloxacillin but with a better safety profile. Notably, benzylpenicillin was associated with less kidney damage, offering improved options for patient care.